nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer
|
Wu, Fengying |
|
|
19 |
6 |
p. e831-e842 |
artikel |
2 |
Bronchoscopic Manifestations of Airway Toxicity After Radiotherapy
|
van Hoorn, Juliët E. |
|
|
19 |
6 |
p. e875-e878 |
artikel |
3 |
Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
|
Helman, Elena |
|
|
19 |
6 |
p. 518-530.e7 |
artikel |
4 |
Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non–Small-cell Lung Cancer: A Systematic Review
|
Zhao, Xuewei |
|
|
19 |
6 |
p. e945-e956 |
artikel |
5 |
Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non–small-cell Lung Cancer: A Two-institution Propensity-matched Analysis
|
Cummings, Michael A. |
|
|
19 |
6 |
p. 511-517 |
artikel |
6 |
Current and Former Smokers: Who Wants To Be Screened?
|
Couraud, Sébastien |
|
|
19 |
6 |
p. 493-501 |
artikel |
7 |
Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non–small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L)
|
Hata, Akito |
|
|
19 |
6 |
p. e865-e869 |
artikel |
8 |
Dynamic Changes and Drug-Induced Selection of Resistant Clones in a Patient With EGFR-Mutated Adenocarcinoma That Acquired T790M Mutation and Transformed to Small-Cell Lung Cancer
|
Iijima, Yuki |
|
|
19 |
6 |
p. e843-e847 |
artikel |
9 |
Editorial Board
|
|
|
|
19 |
6 |
p. A4 |
artikel |
10 |
First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non–Small-cell Lung Cancer With Different Prognostic Significance
|
Iams, Wade T. |
|
|
19 |
6 |
p. 531-543 |
artikel |
11 |
Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non–Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study
|
Xie, Hounai |
|
|
19 |
6 |
p. 484-492 |
artikel |
12 |
Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer
|
Verma, Vivek |
|
|
19 |
6 |
p. 502-510 |
artikel |
13 |
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non–Small-cell Lung Cancer
|
Owen, Dwight H. |
|
|
19 |
6 |
p. e893-e900 |
artikel |
14 |
KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non–small-cell Lung Cancer
|
Renaud, Stéphane |
|
|
19 |
6 |
p. e919-e931 |
artikel |
15 |
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study
|
Akamatsu, Hiroaki |
|
|
19 |
6 |
p. e871-e874 |
artikel |
16 |
PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma
|
Zaric, Bojan |
|
|
19 |
6 |
p. e957-e963 |
artikel |
17 |
Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non–Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care
|
Patel, Jyoti D. |
|
|
19 |
6 |
p. e823-e830 |
artikel |
18 |
Pemetrexed, Vitamin B12, and Thoracic Tumors: The Times, They Are A-Changin’
|
Bironzo, Paolo |
|
|
19 |
6 |
p. 461-463 |
artikel |
19 |
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure
|
Barbie, David A. |
|
|
19 |
6 |
p. e853-e859 |
artikel |
20 |
Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer
|
Wu, Fang |
|
|
19 |
6 |
p. e913-e918 |
artikel |
21 |
Physician Bias in Prophylactic Cranial Irradiation Decision Making—An Opportunity for a Patient Decision Aid
|
Robin, Tyler P. |
|
|
19 |
6 |
p. 476-483 |
artikel |
22 |
Prophylactic Cranial Irradiation Versus Surveillance: Physician Bias and Patient-centered Decision-making
|
Johnson, Skyler B. |
|
|
19 |
6 |
p. 464-466 |
artikel |
23 |
Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
|
Oezkan, Filiz |
|
|
19 |
6 |
p. e879-e884 |
artikel |
24 |
Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non–Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis
|
Schlei, Zachary |
|
|
19 |
6 |
p. 467-475 |
artikel |
25 |
Sex-Dependent Staging in Non–Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System
|
Wainer, Zoe |
|
|
19 |
6 |
p. e933-e944 |
artikel |
26 |
Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non–small-cell Lung Cancer
|
Driessen, Elisabeth J.M. |
|
|
19 |
6 |
p. e849-e852 |
artikel |
27 |
Study Protocol: Phase-Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors
|
Kubo, Toshio |
|
|
19 |
6 |
p. e861-e864 |
artikel |
28 |
Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival
|
Verma, Vivek |
|
|
19 |
6 |
p. e901-e912 |
artikel |
29 |
Table of Contents
|
|
|
|
19 |
6 |
p. A5-A7, A13-A14 |
artikel |
30 |
Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns
|
Farrell, Matthew J. |
|
|
19 |
6 |
p. e815-e821 |
artikel |
31 |
Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis
|
Suzuki, Ryoko |
|
|
19 |
6 |
p. e885-e891 |
artikel |